[Federal Register Volume 86, Number 183 (Friday, September 24, 2021)]
[Notices]
[Pages 53116-53117]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-20760]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-895]


Importer of Controlled Substances Application: Cardinal Health

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Cardinal Health has applied to be registered as an importer of 
basic class(es) of controlled substance(s). Refer to Supplemental 
Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before October 25, 
2021. Such persons may also file a written request for a hearing on the 
application on or before October 25, 2021.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a 
hearing must be sent to: Drug Enforcement Administration, Attn: 
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All 
requests for a hearing should also be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, 
Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this 
is notice that on July 22, 2021, Cardinal Health, 15 Ingram Boulevard, 
La Vergne, Tennessee 37086-3630, applied to be registered as an 
importer of the following basic class(es) of controlled substance(s):

------------------------------------------------------------------------
        Controlled substance            Drug code          Schedule
------------------------------------------------------------------------
Secobarbital.......................            2315  II
Nabilone...........................            7379  II
------------------------------------------------------------------------

    The company plans to import the above controlled substance in 
finished dosage form for distribution to licensed registrants for the 
purpose of medical use only. No other activity for these drug codes is 
authorized for this registration.
    Approval of permit applications will occur only when the 
registrant's

[[Page 53117]]

business activity is consistent with what is authorized under 21 U.S.C. 
952(a)(2).

Brian S. Besser,
Acting Assistant Administrator.
[FR Doc. 2021-20760 Filed 9-23-21; 8:45 am]
BILLING CODE P